{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,31]],"date-time":"2026-07-31T17:43:30Z","timestamp":1785519810985,"version":"3.56.0"},"reference-count":42,"publisher":"BMJ","issue":"1","license":[{"start":{"date-parts":[[2021,9,21]],"date-time":"2021-09-21T00:00:00Z","timestamp":1632182400000},"content-version":"unspecified","delay-in-days":20,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc\/4.0\/"}],"content-domain":{"domain":["bmj.com"],"crossmark-restriction":true},"short-container-title":["BMJ Open Resp Res"],"accepted":{"date-parts":[[2021,8,7]]},"published-print":{"date-parts":[[2021,9]]},"abstract":"<jats:sec>\n                  <jats:title>Importance<\/jats:title>\n                  <jats:p>Use of non-invasive respiratory modalities in COVID-19 has the potential to reduce rates of intubation and mortality in severe disease however data regarding the use of high-flow nasal cannula (HFNC) in this population is limited.<\/jats:p>\n               <\/jats:sec>\n               <jats:sec>\n                  <jats:title>Objective<\/jats:title>\n                  <jats:p>To interrogate clinical and laboratory features of SARS-CoV-2 infection associated with high-flow failure.<\/jats:p>\n               <\/jats:sec>\n               <jats:sec>\n                  <jats:title>Design<\/jats:title>\n                  <jats:p>We conducted a retrospective cohort study to evaluate characteristics of high-flow therapy use early in the pandemic and interrogate factors associated with respiratory therapy failure.<\/jats:p>\n               <\/jats:sec>\n               <jats:sec>\n                  <jats:title>Setting<\/jats:title>\n                  <jats:p>Multisite single centre hospital system within the metropolitan Detroit region.<\/jats:p>\n               <\/jats:sec>\n               <jats:sec>\n                  <jats:title>Participants<\/jats:title>\n                  <jats:p>Patients from within the Detroit Medical Center (n=104, 89% African American) who received HFNC therapy during a COVID-19 admission between March and May of 2020.<\/jats:p>\n               <\/jats:sec>\n               <jats:sec>\n                  <jats:title>Primary outcome<\/jats:title>\n                  <jats:p>HFNC failure is defined as death or intubation while on therapy.<\/jats:p>\n               <\/jats:sec>\n               <jats:sec>\n                  <jats:title>Results<\/jats:title>\n                  <jats:p>Therapy failure occurred in 57% of the patient population, factors significantly associated with failure centred around markers of multiorgan failure including hepatic dysfunction\/transaminitis (OR=6.1, 95% CI 1.9 to 19.4, p&lt;0.01), kidney injury (OR=7.0, 95% CI 2.7 to 17.8, p&lt;0.01) and coagulation dysfunction (OR=4.5, 95% CI 1.2 to 17.1, p=0.03). Conversely, comorbidities, admission characteristics, early oxygen requirements and evaluation just prior to HFNC therapy initiation were not significantly associated with success or failure of therapy.<\/jats:p>\n               <\/jats:sec>\n               <jats:sec>\n                  <jats:title>Conclusions<\/jats:title>\n                  <jats:p>In a population disproportionately affected by COVID-19, we present key indicators of likely HFNC failure and highlight a patient population in which aggressive monitoring and intervention are warranted.<\/jats:p>\n               <\/jats:sec>","DOI":"10.1136\/bmjresp-2021-000875","type":"journal-article","created":{"date-parts":[[2021,9,22]],"date-time":"2021-09-22T00:10:52Z","timestamp":1632269452000},"page":"e000875","update-policy":"https:\/\/doi.org\/10.1136\/crossmarkpolicy","source":"Crossref","is-referenced-by-count":2,"title":["High-flow nasal cannula therapy in a predominantly African American population with COVID-19 associated acute respiratory failure"],"prefix":"10.1136","volume":"8","author":[{"ORCID":"https:\/\/orcid.org\/0000-0001-7998-293X","authenticated-orcid":false,"given":"Paul L","family":"Nguyen","sequence":"first","affiliation":[{"name":"Department of Internal Medicine, Wayne State University School of Medicine, Detroit, Michigan, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Heba","family":"Osman","sequence":"additional","affiliation":[{"name":"Department of Medicine and Pediatrics, Wayne State University School of Medicine, Detroit, Michigan, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Donovan","family":"Watza","sequence":"additional","affiliation":[{"name":"Department of Internal Medicine, Wayne State University School of Medicine, Detroit, Michigan, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Suman","family":"Khicher","sequence":"additional","affiliation":[{"name":"Department of Internal Medicine, Wayne State University School of Medicine, Detroit, Michigan, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Aditi","family":"Sharma","sequence":"additional","affiliation":[{"name":"Department of Internal Medicine, Wayne State University School of Medicine, Detroit, Michigan, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Greg","family":"Dyson","sequence":"additional","affiliation":[{"name":"Department of Oncology, Bioinformatics and Biostatistics Core, Wayne State University School of Medicine, Detroit, Michigan, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ghulam","family":"Saydain","sequence":"additional","affiliation":[{"name":"Division of Pulmonary and Critical Care, Wayne State University School of Medicine, Detroit, Michigan, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ayman","family":"Soubani","sequence":"additional","affiliation":[{"name":"Division of Pulmonary and Critical Care, Wayne State University School of Medicine, Detroit, Michigan, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"239","published-online":{"date-parts":[[2021,9,21]]},"reference":[{"key":"2025083109485965000_8.1.e000875.1","unstructured":"WHO director-general\u2019s opening remarks at the media briefing on COVID-19, 2020. Available: https:\/\/www.who.int\/director-general\/speeches\/detail\/who-director-general-s-opening-remarks-at-the-media-briefing-on-covid-19-11-march-2020 [Accessed 06 Dec 2020]."},{"key":"2025083109485965000_8.1.e000875.2","unstructured":"Home - johns hopkins coronavirus resource center [internet]. Available: https:\/\/coronavirus.jhu.edu\/ [Accessed 06 Dec 2020]."},{"key":"2025083109485965000_8.1.e000875.3","doi-asserted-by":"publisher","DOI":"10.1001\/jama.2020.2648"},{"key":"2025083109485965000_8.1.e000875.4","doi-asserted-by":"crossref","first-page":"37","DOI":"10.1016\/j.annepidem.2020.05.003","article-title":"Assessing differential impacts of COVID-19 on black communities","volume":"47","author":"Millett","year":"2020","journal-title":"Ann Epidemiol"},{"key":"2025083109485965000_8.1.e000875.5","unstructured":"Whitmer - governor whitmer signs executive order creating the michigan coronavirus task force on racial disparities [Internet]. Available: https:\/\/www.michigan.gov\/whitmer\/0,9309,7-387-90499-526478--,00.html [Accessed 21 Dec 2020]."},{"key":"2025083109485965000_8.1.e000875.6","doi-asserted-by":"crossref","first-page":"2126","DOI":"10.1056\/NEJMra1208707","article-title":"Ventilator-induced lung injury","volume":"369","author":"Slutsky","year":"2013","journal-title":"N Engl J Med Overseas Ed"},{"key":"2025083109485965000_8.1.e000875.7","doi-asserted-by":"publisher","DOI":"10.1001\/jama.287.3.345"},{"key":"2025083109485965000_8.1.e000875.8","doi-asserted-by":"publisher","DOI":"10.1038\/sj.jp.7211647"},{"key":"2025083109485965000_8.1.e000875.9","first-page":"232","article-title":"Clinical experience of high-flow nasal cannula oxygen therapy in severe COVID-19 patients","volume":"49","author":"He","year":"2020","journal-title":"Zhejiang Da Xue Xue Bao Yi Xue Ban [Internet]"},{"key":"2025083109485965000_8.1.e000875.10","doi-asserted-by":"crossref","first-page":"444","DOI":"10.1016\/j.hrtlng.2020.03.018","article-title":"High flow nasal cannula is a good treatment option for COVID-19","volume":"49","author":"Geng","year":"2020","journal-title":"Heart Lung"},{"key":"2025083109485965000_8.1.e000875.11","doi-asserted-by":"crossref","DOI":"10.1186\/s13613-020-00653-z","article-title":"The experience of high-flow nasal cannula in hospitalized patients with 2019 novel coronavirus-infected pneumonia in two hospitals of Chongqing, China","volume":"10","author":"Wang","year":"2020","journal-title":"Ann Intensive Care"},{"key":"2025083109485965000_8.1.e000875.12","doi-asserted-by":"crossref","unstructured":"Panadero C , Abad-Fern\u00e1ndez A , Rio-Ram\u00edrez M\u00aa Teresa , et al . High-flow nasal cannula for acute respiratory distress syndrome (ARDS) due to COVID-19. Multidiscip Respir Med 2020;15 https:\/\/pubmed-ncbi-nlm-nih-gov.proxy.lib.wayne.edu\/32983456\/ doi:10.4081\/mrm.2020.693","DOI":"10.4081\/mrm.2020.693"},{"key":"2025083109485965000_8.1.e000875.13","doi-asserted-by":"publisher","DOI":"10.1016\/j.jcrc.2011.07.075"},{"key":"2025083109485965000_8.1.e000875.14","doi-asserted-by":"publisher","DOI":"10.4187\/respcare.01681"},{"key":"2025083109485965000_8.1.e000875.15","doi-asserted-by":"publisher","DOI":"10.1007\/s00134-011-2354-6"},{"key":"2025083109485965000_8.1.e000875.16","doi-asserted-by":"crossref","DOI":"10.1007\/s00134-019-05658-2","article-title":"High-flow nasal cannula compared with conventional oxygen therapy for acute hypoxemic respiratory failure: author\u2019s reply","volume":"45","author":"Rochwerg","year":"2019","journal-title":"Intensive Care Med"},{"key":"2025083109485965000_8.1.e000875.17","doi-asserted-by":"publisher","DOI":"10.4187\/respcare.04026"},{"key":"2025083109485965000_8.1.e000875.18","doi-asserted-by":"publisher","DOI":"10.1001\/jama.2019.14901"},{"key":"2025083109485965000_8.1.e000875.19","doi-asserted-by":"crossref","first-page":"487","DOI":"10.5935\/0103-507X.20180070","article-title":"The effects of high-flow nasal cannula on intubation and re-intubation in critically ill patients: a systematic review, meta-analysis and trial sequential analysis","volume":"30","author":"Bocchile","year":"2018","journal-title":"Rev Bras Ter Intensiva"},{"key":"2025083109485965000_8.1.e000875.20","doi-asserted-by":"publisher","DOI":"10.1503\/cmaj.160570"},{"key":"2025083109485965000_8.1.e000875.21","doi-asserted-by":"crossref","first-page":"764-775","DOI":"10.1016\/j.chest.2017.01.004","article-title":"Can high-flow nasal cannula reduce the rate of endotracheal intubation in adult patients with acute respiratory failure compared with conventional oxygen therapy and noninvasive positive pressure ventilation?: a systematic review and meta-analysis","volume":"151","author":"Ni","year":"2017","journal-title":"Chest"},{"key":"2025083109485965000_8.1.e000875.22","unstructured":"Clinical management of COVID-19 [Internet]. Available: https:\/\/www.who.int\/publications\/i\/item\/clinical-management-of-covid-19 [Accessed 06 Dec 2020]."},{"key":"2025083109485965000_8.1.e000875.23","doi-asserted-by":"publisher","DOI":"10.1097\/CCM.0000000000004363"},{"key":"2025083109485965000_8.1.e000875.24","doi-asserted-by":"crossref","unstructured":"Li J , Fink JB , Ehrmann S . High-flow nasal cannula for COVID-19 patients: Risk of bio-aerosol dispersion. Eur Respir J 2020;56. doi:doi:10.1183\/13993003.03136-2020. [Epub ahead of print: Available from] https:\/\/pubmed-ncbi-nlm-nih-gov.proxy.lib.wayne.edu\/32299867\/","DOI":"10.1183\/13993003.03136-2020"},{"key":"2025083109485965000_8.1.e000875.25","doi-asserted-by":"publisher","DOI":"10.1136\/bmjresp-2020-000650"},{"key":"2025083109485965000_8.1.e000875.26","doi-asserted-by":"publisher","DOI":"10.1136\/thoraxjnl-2020-214993"},{"key":"2025083109485965000_8.1.e000875.27","doi-asserted-by":"crossref","first-page":"521","DOI":"10.1002\/emp2.12152","article-title":"Aerosol risk with noninvasive respiratory support in patients with COVID\u201019","volume":"1","author":"Miller","year":"2020","journal-title":"J Am Coll Emerg Physicians Open"},{"key":"2025083109485965000_8.1.e000875.28","doi-asserted-by":"publisher","DOI":"10.1164\/rccm.201810-2050CP"},{"key":"2025083109485965000_8.1.e000875.29","doi-asserted-by":"publisher","DOI":"10.1001\/dmp.2010.40"},{"key":"2025083109485965000_8.1.e000875.30","doi-asserted-by":"publisher","DOI":"10.1001\/jama.2020.1585"},{"key":"2025083109485965000_8.1.e000875.31","unstructured":"MDHHS - coronavirus task force on racial disparities [Internet]. Available: https:\/\/www.michigan.gov\/mdhhs\/0,5885,7-339-71551_5460_99929---,00.html [Accessed 31 Dec 2020]."},{"key":"2025083109485965000_8.1.e000875.32","doi-asserted-by":"publisher","DOI":"10.4187\/respcare.03423"},{"key":"2025083109485965000_8.1.e000875.33","doi-asserted-by":"publisher","DOI":"10.1164\/rccm.201803-0589OC"},{"key":"2025083109485965000_8.1.e000875.34","doi-asserted-by":"crossref","first-page":"475","DOI":"10.1016\/S2213-2600(20)30079-5","article-title":"Clinical course and outcomes of critically ill patients with SARS-CoV-2 pneumonia in Wuhan, China: a single-centered, retrospective, observational study","volume":"8","author":"Yang","year":"2020","journal-title":"Lancet Respir Med"},{"key":"2025083109485965000_8.1.e000875.35","doi-asserted-by":"crossref","first-page":"934","DOI":"10.1001\/jamainternmed.2020.0994","article-title":"Risk factors associated with acute respiratory distress syndrome and death in patients with coronavirus disease 2019 pneumonia in Wuhan, China","volume":"180","author":"Wu","year":"2020","journal-title":"JAMA Intern Med"},{"key":"2025083109485965000_8.1.e000875.36","doi-asserted-by":"publisher","DOI":"10.1164\/rccm.202005-2007LE"},{"key":"2025083109485965000_8.1.e000875.37","doi-asserted-by":"crossref","first-page":"2099","DOI":"10.1001\/jama.2018.14282","article-title":"Effect of high-flow nasal oxygen vs standard oxygen on 28-day mortality in immunocompromised patients with acute respiratory failure: the high randomized clinical trial","volume":"320","author":"Azoulay","year":"2018","journal-title":"JAMA"},{"key":"2025083109485965000_8.1.e000875.38","doi-asserted-by":"crossref","first-page":"1124","DOI":"10.1007\/s00134-020-06057-8","article-title":"Time to consider histologic pattern of lung injury to treat critically ill patients with COVID-19 infection","volume":"46","author":"Copin","year":"2020","journal-title":"Intensive Care Med"},{"key":"2025083109485965000_8.1.e000875.39","doi-asserted-by":"crossref","first-page":"350","DOI":"10.7326\/M20-2566","article-title":"Pulmonary arterial thrombosisarterial thrombosis in COVID-19 with fatal outcomewith fatal outcome : results from a prospective, single-center, clinicopathologic case seriesresults from a prospective, single-center, clinicopathologic case series","volume":"173","author":"Lax","year":"2020","journal-title":"Ann Intern Med"},{"key":"2025083109485965000_8.1.e000875.40","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMc2011400"},{"key":"2025083109485965000_8.1.e000875.41","doi-asserted-by":"publisher","DOI":"10.1007\/s00134-015-3693-5"},{"key":"2025083109485965000_8.1.e000875.42","doi-asserted-by":"crossref","first-page":"1300","DOI":"10.1164\/rccm.201901-0079ED","article-title":"Predicting outcomes of high-flow nasal cannula for acute respiratory distress syndrome. An index that roX","volume":"199","author":"Hill","year":"2019","journal-title":"Am J Respir Crit Care Med"}],"container-title":["BMJ Open Respiratory Research"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/syndication.highwire.org\/content\/doi\/10.1136\/bmjresp-2021-000875","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,8,31]],"date-time":"2025-08-31T16:49:11Z","timestamp":1756658951000},"score":1,"resource":{"primary":{"URL":"https:\/\/bmjopenrespres.bmj.com\/lookup\/doi\/10.1136\/bmjresp-2021-000875"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,9]]},"references-count":42,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2021,9,21]]},"published-print":{"date-parts":[[2021,9]]}},"alternative-id":["10.1136\/bmjresp-2021-000875"],"URL":"https:\/\/doi.org\/10.1136\/bmjresp-2021-000875","relation":{},"ISSN":["2052-4439"],"issn-type":[{"value":"2052-4439","type":"electronic"}],"subject":[],"published":{"date-parts":[[2021,9]]}}}